NCT00771004 - Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Oxidative StressCoronary Artery DiseaseType 2 Diabetes

Interventions

DRUG

Pioglitazone

Pioglitazone 30 mg, tablets, orally, once daily for one week; increased to Pioglitazone 45 mg, tablets, orally, once daily for up to two weeks.

DRUG

Placebo

Pioglitazone placebo-matching tablets, orally, once daily for up to three weeks.

Trial Locations (7)

Hamburg

Frankfurt am Main

Kassel

Wiesbaden

Wuppertal

Mainz

Jena